Ordinary Share Capital Endring Dato
Acadia Pharmaceuticals USD 16K 0 2023-12
Agios Pharmaceuticals USD 72K 0 2023-12
Alnylam Pharmaceuticals USD 1.26M 4K 2023-12
Amgen USD 32.75B 152M 2023-09
Bayer EUR 2.52B 0 2023-09
Biogen USD 100K 0 2023-12
BioMarin Pharmaceutical USD 189K 1000 2023-12
Bluebird Bio USD 1.07M 6K 2023-09
Gilead Sciences USD 1000K 0 2023-09
Incyte USD 224K 0 2023-12
Insmed USD 1.48M 50K 2023-12
Ionis Pharmaceuticals USD 144K 1000 2023-12
Moderna USD 38.2K 100 2023-12
Neurocrine Biosciences USD 100K 0 2023-09
PTC Therapeutics USD 75K 0 2023-12
Regeneron Pharmaceuticals USD 102K 0 2023-09
Roche Holding CHF 107M 0 2023-06
Sarepta Therapeutics USD 9K 0 2023-09
Ultragenyx Pharmaceutical USD 72K 1000 2023-09
United Therapeutics USD 700K 0 2023-12
Vertex Pharmaceuticals USD 2.6M 0 2023-09



BioMarin Pharmaceutical Ordinære Aksjekapital - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2024.